相关实验视频
Updated: Jul 26, 2025

05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
6.7K
中央皮里丁衍生的TYK2 JH2抑制剂的结构-活性关系研究:通过C4'和C6变异优化PK概况
Zili Xiao1, Michael G Yang1, Chunjian Liu1
1Research and Development, Bristol-Myers Squibb Company, Princeton, NJ 08543-4000, United States.
Bioorganic & medicinal chemistry letters
|June 14, 2023
概括
研究人员通过结构-活性关系研究开发出一种强大的TYK2 JH2 抑制剂4h. 这种新化合物与早期的抑制剂有明显的结构差异,并显示出有希望的体外和体内疗效.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 第一个代TYK2 JH2抑制剂,以化合物1a为例,作为进一步开发的起点.
- 提高TYK2 JH2抑制剂的功效和探索结构多样性是关键目标.
研究的目的:
- 对新的基于的类似物进行结构-活性关系 (SAR) 研究.
- 识别和描述新型,强效和选择性的TYK2 JH2 抑制剂.
- 评估化合物的体外和体外特征.
主要方法:
- 合成和SAR分析基于的类似物 (化合物2-4).
- 在体外生化测试以确定抑制度 (IC50).
- 在小鼠体内药理动力学 (PK) 研究以评估生物可用性.
主要成果:
- 化合物4h作为一种强效和选择性的TYK2 JH2 抑制剂的鉴定.
- 与第一代抑制剂1a相比,化合物4h具有独特的结构特征.
- 在体外:4h表明hWB IC50为41nM.
- 在体内:4h在小鼠PK研究中显示了94%的生物可用性.
结论:
- 化合物4h代表了TYK2 JH2 抑制剂开发的重大进展.
- 确定的化合物具有良好的体外功效和体内药理动力学特征.
- 进一步研究4h的治疗潜力是有必要的.
相关概念视频
Structure-Activity Relationships and Drug Design
800
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
800
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K
Basicity of Heterocyclic Aromatic Amines
6.1K
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
6.1K
Aromatic Hydrocarbon Cations: Structural Overview
2.9K
Cycloheptatriene is a neutral monocyclic unsaturated hydrocarbon that consists of an odd number of carbon atoms and an intervening sp3 carbon in the ring. The three double bonds in the ring correspond to 6 π electrons, which is a Huckel number, and therefore satisfies the criteria of 4n + 2 π electrons. However, the intervening sp3 carbon disrupts the continuous overlap of p orbitals. As a result, cycloheptatriene is not aromatic.
Removing one hydrogen from the intervening CH2 group...
Removing one hydrogen from the intervening CH2 group...
2.9K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.1K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
608
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
608

